Correlation between cognitive impairment and serum phosphorylated tau181 protein in patients with preeclampsia

ObjectiveTo study the cognitive function status, serum phosphorylated tau181 (P-tau181) protein level, and total tau (T-tau) protein level in patients with preeclampsia (PE), pregnant healthy controls (PHCs), and non-pregnant healthy controls (NPHCs), and to research their feasibility as serum bioma...

Full description

Bibliographic Details
Main Authors: Yuanyuan Wang, Bin Guo, Ke Zhao, Linfeng Yang, Tao Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-03-01
Series:Frontiers in Aging Neuroscience
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fnagi.2023.1148518/full
_version_ 1797858943904514048
author Yuanyuan Wang
Bin Guo
Ke Zhao
Linfeng Yang
Tao Chen
author_facet Yuanyuan Wang
Bin Guo
Ke Zhao
Linfeng Yang
Tao Chen
author_sort Yuanyuan Wang
collection DOAJ
description ObjectiveTo study the cognitive function status, serum phosphorylated tau181 (P-tau181) protein level, and total tau (T-tau) protein level in patients with preeclampsia (PE), pregnant healthy controls (PHCs), and non-pregnant healthy controls (NPHCs), and to research their feasibility as serum biomarkers for evaluating cognitive functional impairment in PE patients.MethodsSixty-eight patients with PE, 48 NPHCs, and 30 PHCs were included. Cognitive functional status was assessed using standardized Symbol Digit Modalities Test (SDMT) and Montreal Cognitive Assessment (MoCA) scales. Enzyme-linked immunosorbent assay (ELISA) was used to detect the level of serum P-tau181 and T-tau protein. The concentration of serum P-tau181 and T-tau protein were compared by one-way analysis of variance in the three groups of subjects. The correlation between P-tau181, T-tau, and SDMT was explore by multiple linear regression analysis. The areas under the receiver operating characteristic (ROC) curves of serum P-tau181 and SDMT were calculated to predict the cognitive level of subjects.ResultsPE patients significantly had lower scores on SDMT (47.97 ± 7.54) and MoCA (28.00 ± 2.00) than normotensive PHCs (30.00 ± 1.25, 54.73 ± 8.55, respectively). The significant difference was found in serum P-tau181 protein levels among the three groups [H(K) = 19.101, P < 0.001]. Serum P-tau181 was thicker in PE patients than PHCs or NPHCs (both P < 0.05). According to the ROC curve, T-tau had no statistical significance in predicting the ability of cognizance, while P-tau181 and SDMT had. The DeLong test showed that P-tau181 was better than T-tau in predicting the ability of cognizance (P < 0.05).ConclusionThe patients with PE have occurred the decline of cognitive function during pregnancy. The high level of serum P-tau181 can be used as a clinical laboratory indication for non-invasive assessment of cognitive functional impairment in PE patients.
first_indexed 2024-04-09T21:21:33Z
format Article
id doaj.art-63ccd409890a4a96b2cb85b388a2e3a1
institution Directory Open Access Journal
issn 1663-4365
language English
last_indexed 2024-04-09T21:21:33Z
publishDate 2023-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Aging Neuroscience
spelling doaj.art-63ccd409890a4a96b2cb85b388a2e3a12023-03-28T05:24:50ZengFrontiers Media S.A.Frontiers in Aging Neuroscience1663-43652023-03-011510.3389/fnagi.2023.11485181148518Correlation between cognitive impairment and serum phosphorylated tau181 protein in patients with preeclampsiaYuanyuan Wang0Bin Guo1Ke Zhao2Linfeng Yang3Tao Chen4Department of Radiology, Binzhou Medical University, Yantai, Shandong, ChinaDepartment of Radiology, Jinan Maternity and Child Care Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, ChinaDepartment of Clinical Laboratory, Jinan Maternity and Child Care Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, ChinaDepartment of Radiology, Jinan Maternity and Child Care Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, ChinaDepartment of Clinical Laboratory, Jinan Maternity and Child Care Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, ChinaObjectiveTo study the cognitive function status, serum phosphorylated tau181 (P-tau181) protein level, and total tau (T-tau) protein level in patients with preeclampsia (PE), pregnant healthy controls (PHCs), and non-pregnant healthy controls (NPHCs), and to research their feasibility as serum biomarkers for evaluating cognitive functional impairment in PE patients.MethodsSixty-eight patients with PE, 48 NPHCs, and 30 PHCs were included. Cognitive functional status was assessed using standardized Symbol Digit Modalities Test (SDMT) and Montreal Cognitive Assessment (MoCA) scales. Enzyme-linked immunosorbent assay (ELISA) was used to detect the level of serum P-tau181 and T-tau protein. The concentration of serum P-tau181 and T-tau protein were compared by one-way analysis of variance in the three groups of subjects. The correlation between P-tau181, T-tau, and SDMT was explore by multiple linear regression analysis. The areas under the receiver operating characteristic (ROC) curves of serum P-tau181 and SDMT were calculated to predict the cognitive level of subjects.ResultsPE patients significantly had lower scores on SDMT (47.97 ± 7.54) and MoCA (28.00 ± 2.00) than normotensive PHCs (30.00 ± 1.25, 54.73 ± 8.55, respectively). The significant difference was found in serum P-tau181 protein levels among the three groups [H(K) = 19.101, P < 0.001]. Serum P-tau181 was thicker in PE patients than PHCs or NPHCs (both P < 0.05). According to the ROC curve, T-tau had no statistical significance in predicting the ability of cognizance, while P-tau181 and SDMT had. The DeLong test showed that P-tau181 was better than T-tau in predicting the ability of cognizance (P < 0.05).ConclusionThe patients with PE have occurred the decline of cognitive function during pregnancy. The high level of serum P-tau181 can be used as a clinical laboratory indication for non-invasive assessment of cognitive functional impairment in PE patients.https://www.frontiersin.org/articles/10.3389/fnagi.2023.1148518/fullpreeclampsiacognitive functiontau proteinserum phosphorylated tau181 protein (P-tau181)Symbol Digit Modalities Test (SDMT)
spellingShingle Yuanyuan Wang
Bin Guo
Ke Zhao
Linfeng Yang
Tao Chen
Correlation between cognitive impairment and serum phosphorylated tau181 protein in patients with preeclampsia
Frontiers in Aging Neuroscience
preeclampsia
cognitive function
tau protein
serum phosphorylated tau181 protein (P-tau181)
Symbol Digit Modalities Test (SDMT)
title Correlation between cognitive impairment and serum phosphorylated tau181 protein in patients with preeclampsia
title_full Correlation between cognitive impairment and serum phosphorylated tau181 protein in patients with preeclampsia
title_fullStr Correlation between cognitive impairment and serum phosphorylated tau181 protein in patients with preeclampsia
title_full_unstemmed Correlation between cognitive impairment and serum phosphorylated tau181 protein in patients with preeclampsia
title_short Correlation between cognitive impairment and serum phosphorylated tau181 protein in patients with preeclampsia
title_sort correlation between cognitive impairment and serum phosphorylated tau181 protein in patients with preeclampsia
topic preeclampsia
cognitive function
tau protein
serum phosphorylated tau181 protein (P-tau181)
Symbol Digit Modalities Test (SDMT)
url https://www.frontiersin.org/articles/10.3389/fnagi.2023.1148518/full
work_keys_str_mv AT yuanyuanwang correlationbetweencognitiveimpairmentandserumphosphorylatedtau181proteininpatientswithpreeclampsia
AT binguo correlationbetweencognitiveimpairmentandserumphosphorylatedtau181proteininpatientswithpreeclampsia
AT kezhao correlationbetweencognitiveimpairmentandserumphosphorylatedtau181proteininpatientswithpreeclampsia
AT linfengyang correlationbetweencognitiveimpairmentandserumphosphorylatedtau181proteininpatientswithpreeclampsia
AT taochen correlationbetweencognitiveimpairmentandserumphosphorylatedtau181proteininpatientswithpreeclampsia